Daniel Pearce

914 total citations
17 papers, 698 citations indexed

About

Daniel Pearce is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Daniel Pearce has authored 17 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Emergency Medicine. Recurrent topics in Daniel Pearce's work include HIV/AIDS Research and Interventions (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV-related health complications and treatments (4 papers). Daniel Pearce is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and HIV-related health complications and treatments (4 papers). Daniel Pearce collaborates with scholars based in United States, United Kingdom and Australia. Daniel Pearce's co-authors include Lawrence J. Eron, D. William Cameron, Paul M. Sullam, Richard E. Chaisson, David L. Cohn, John J. Stern, David L. Kaufman, Anthony LaMarca, Frederick P. Siegal and Fred M. Gordin and has published in prestigious journals such as New England Journal of Medicine, The American Journal of Cardiology and AIDS.

In The Last Decade

Daniel Pearce

17 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Pearce United States 10 378 347 86 73 72 17 698
Daniel Fuster Spain 19 199 0.5× 658 1.9× 93 1.1× 66 0.9× 59 0.8× 66 1.0k
Ross G. Hewitt United States 16 376 1.0× 205 0.6× 77 0.9× 170 2.3× 62 0.9× 34 714
Maria José Míguez‐Burbano United States 15 353 0.9× 224 0.6× 166 1.9× 170 2.3× 27 0.4× 34 705
Kevin Gough Canada 16 513 1.4× 382 1.1× 125 1.5× 156 2.1× 43 0.6× 43 1.0k
Birgit Kvinesdal Denmark 14 308 0.8× 202 0.6× 77 0.9× 215 2.9× 96 1.3× 35 754
D. Henzel France 22 231 0.6× 225 0.6× 164 1.9× 95 1.3× 71 1.0× 59 1.1k
Daniela Zaknun Austria 11 199 0.5× 150 0.4× 75 0.9× 103 1.4× 17 0.2× 18 558
Anna Christen Switzerland 9 196 0.5× 147 0.4× 58 0.7× 90 1.2× 21 0.3× 10 435
Sima S. Toussi United States 14 342 0.9× 213 0.6× 16 0.2× 99 1.4× 64 0.9× 26 776
Toshibumi Taniguchi Japan 14 356 0.9× 132 0.4× 40 0.5× 76 1.0× 25 0.3× 56 648

Countries citing papers authored by Daniel Pearce

Since Specialization
Citations

This map shows the geographic impact of Daniel Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pearce more than expected).

Fields of papers citing papers by Daniel Pearce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pearce. The network helps show where Daniel Pearce may publish in the future.

Co-authorship network of co-authors of Daniel Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Pearce. A scholar is included among the top collaborators of Daniel Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Pearce. Daniel Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Stafylis, Chrysovalantis, Daniel Pearce, Jeff Taylor, et al.. (2021). Interest, Concerns, and Attitudes Among Men Who Have Sex With Men and Health Care Providers Toward Prophylactic Use of Doxycycline Against Chlamydia trachomatis Infections and Syphilis. Sexually Transmitted Diseases. 48(9). 615–619. 34 indexed citations
2.
Ly, Judy, Tommy Saing, Hicret Islamoglu, et al.. (2017). Restoring Cytokine Balance in HIV-Positive Individuals with Low CD4 T Cell Counts. AIDS Research and Human Retroviruses. 33(9). 905–918. 44 indexed citations
4.
Saing, Tommy, et al.. (2016). Data on pro-inflammatory cytokines IL-1β, IL-17, and IL-6 in the peripheral blood of HIV-infected individuals. Data in Brief. 8. 1044–1047. 5 indexed citations
5.
Ly, Judy, Tommy Saing, Manpreet Singh, et al.. (2015). Liposomal Glutathione Supplementation Restores T H 1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals. Journal of Interferon & Cytokine Research. 35(11). 875–887. 55 indexed citations
6.
Pearce, Daniel, Katherine Mitsouras, & Kristopher Irizarry. (2014). Discriminating the Effects of Cannabis sativa and Cannabis indica: A Web Survey of Medical Cannabis Users. The Journal of Alternative and Complementary Medicine. 20(10). 787–791. 36 indexed citations
7.
Wang, Zhijun, et al.. (2013). A Survey of a Small Sample of Emergency Department and Admitted Patients Asking Whether They Expect to Be Tested for HIV Routinely. Journal of the International Association of Providers of AIDS Care (JIAPAC). 12(4). 247–252. 7 indexed citations
8.
Pearce, Daniel, et al.. (2012). Comparison of In-Hospital Mortality from Acute Myocardial Infarction in HIV Sero-Positive Versus Sero-Negative Individuals. The American Journal of Cardiology. 110(8). 1078–1084. 39 indexed citations
9.
Talal, Andrew H., Marija Zeremski, Rositsa B. Dimova, et al.. (2011). Randomized Trial Comparing Dose Reduction and Growth Factor Supplementation for Management of Hematological Side Effects in HIV/Hepatitis C Virus Patients Receiving Pegylated-Interferon and Ribavirin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(3). 261–268. 8 indexed citations
10.
Guerra, Carlos, et al.. (2011). Control ofMycobacterium tuberculosisgrowth by activated natural killer cells. Clinical & Experimental Immunology. 168(1). 142–152. 58 indexed citations
11.
Martínez, Estebán, Fehmida Visnegarwala, Birgit Grund, et al.. (2010). The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters. AIDS. 24(3). 353–563. 12 indexed citations
12.
Pearce, Daniel, et al.. (2008). A Case Report of Recurrent Salmonella Meningitis in an Adult AIDS Patient in the United States. Journal of the International Association of Physicians in AIDS Care. 7(5). 220–222. 3 indexed citations
13.
DeJesus, Edwin, et al.. (2007). Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients. Journal of the International Association of Physicians in AIDS Care. 6(2). 95–100. 31 indexed citations
14.
Lim, Michael J., et al.. (2006). Upregulation of the pro-inflammatory cytokine IL1 beta in the Neuronal Ceroid Lipofuscinoses. Developmental Medicine & Child Neurology. 48. 6–6. 1 indexed citations
16.
Cheung, Tony, Dushyantha Jayaweera, Daniel Pearce, et al.. (2000). Safety of oral versus intravenous hydration during induction therapy with intravenous foscarnet in AIDS patients with cytomegalovirus infections. International Journal of STD & AIDS. 11(10). 640–647. 6 indexed citations
17.
Nightingale, Stephen D., D. William Cameron, Fred M. Gordin, et al.. (1993). Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS. New England Journal of Medicine. 329(12). 828–833. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026